PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells
- 15 November 2002
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 109 (1-3) , 115-125
- https://doi.org/10.1016/s0167-0115(02)00194-5
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Defective death receptor signaling as a cause of tumor immune escapeSeminars in Cancer Biology, 2002
- Fas and FasL in the homeostatic regulation of immune responsesPublished by Elsevier ,2001
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999
- PACAP hybrid: A new PACAP receptor antagonistLife Sciences, 1997
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Cloning of a Splice Variant of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Type I ReceptorBiochemical and Biophysical Research Communications, 1993
- Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)Biochemical and Biophysical Research Communications, 1990
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989